Pralsetinib + P Gp Or Bcrp Substrates Interaction
Majorinteraction on record
Description
Concomitant use increases pralsetinib exposure, which may increase the risk of adverse reactions. Avoid coadministration; if unavoidable, reduce GAVRETO dose.
Mechanism
P-gp inhibition increases pralsetinib exposure
Source: NLP:pralsetinib